IMGM Laboratories GmbH, a leading service provider for advanced genomic services, recently announced that it has attained the certificate of Good Laboratory Practice (GLP) compliance issued by the Bavarian Health and Food Safety Authority.
GLP is a quality system regulating the organizational process and the conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived and reported.
"GLP perfectly complements IMGM’s ISO 17025 accreditation and GCP QM system" says Michael Haberl, IMGM’s Head of Quality Assurance. "ISO 17025 elements like document control, validation, internal audits and CAPA ensured our data’s quality for more than a decade. In 2012, we added GCP (Good Clincial Practice) elements including controlled archives for documents. Now, we implemented GLP specific requirements including controlled archives for retention samples and the maintenance of a master schedule to add regulatory compliance for pre-clinical studies."
Amelie Schreieck, IMGM Project Manager, comments: "Having performed genomic analyses like biodistribution studies in the context of ATMP development to analyse the persistence of nucleic acid therapeutics in target and non-target tissues, we already had the practical infrastructure for pre-clinical studies established for years. With the GLP certificate attesting regulatory compliance, our customers can now rely on regulatory authorities’ general acceptance of IMGM’s data as being of sufficient quality, precision and reproducibility."
About IMGM Laboratories GmbH
IMGM is a leading genomic service provider with a focus on Biomarker Discovery, Biodistribution, Pharmacogenetics and Metagenomics. With NGS, microarray and qPCR state-of-the-art technology as well as competency in complex data analysis the company offers tailored solutions to customers from pharma, diagnostics, biotech and academia. Quality, experience, motivation and a strong background in molecular genetics and medical diagnostics make IMGM a valuable partner for genetic analysis in pre-clinical and clinical studies.
IMGM is looking forward to support your GLP research projects including biodistribution and other pre-clinical studies with its expertise and its advanced methods in NGS, microarray and qPCR.
Get in touch with our team via our contact sheet or call +49.89.4524667.0. For more information on IMGM’s service portfolio check out our homepage www.IMGM.com